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ABSTRACT OF THE DISSERTATION

Secretory IgA enhances gut B cells priming and systemic IgG responses towards commensals
by
You Zhou
Doctor of Philosophy in Biology and Biomedical Sciences
Immunology
Washington University in St. Louis, 2019
Professor Chyi-Song Hsieh, Chair

IgA is the primary antibody response at mucosal surfaces and is reported to inhibit adaptive
immune responses against gut bacteria. Here, we utilize an in vitro system to expand and screen
IgA memory B cells for their ability to recognize gut bacteria in the context of secretory IgA
(sIgA) deficiency in polymeric Ig receptor (Pigr–/–) mice. Contrary to the prevailing hypothesis
that IgA provides an immune exclusionary function, we found that mice lacking sIgA showed
decreased anti-bacterial IgA specificities as assessed using flow cytometry. IgA B cell responses
against certain taxa such as those of order Bacteriodales showed greater dependence on sIgA.
Notably, sIgA also facilitated the generation of anti-bacterial IgG B cells, which provided
increased resistance to intraperitoneal infection by commensal bacteria. Together, these data
suggest that sIgA can facilitate the immune priming of gut commensals to increase anti-bacterial
IgA and IgG and enhance immunity.

vi

Chapter 1: Introduction
The mammalian gastro-intestinal tract is colonized by trillions of microbes, many of
which perform symbiotic functions for the benefit of both the host and commensal. However, in
certain circumstances, colonization of the gut by pathogenic species and virulent penetration into
the host has been shown to result in pathology (Coburn et al., 2007; Thomson et al., 2011). Thus,
in order to maintain homeostasis, various host mechanisms have evolved to interact with the
commensal bacterial population. One layer of protection is thought to be provided by adaptive
immunity via the secretion of immunoglobulins (Ig) by B cells. While various Ig isotypes are
produced in the mucosa, secretory IgA (sIgA) is the primary antibody that enters the lumen.
Recent studies demonstrate the multi-faceted approach in which sIgA can affect the host-microbe
interaction, oftentimes in the context of pathogenic infection. What is less clear, is the role of
sIgA responses during homeostatic conditions. In this thesis, we analyze the impact of sIgA
deficiency on the gut immune system, demonstrate the ability of sIgA to enhance the priming of
both IgA and IgG memory B cell responses towards commensals, and show the consequences of
sIgA deficiency during septic challenge by commensal bacteria.

Activation of IgA B cells in the gut.
The gut IgA B cell compartment develops from naïve B cells of both B1 and B2 origin.
Naïve B-1 cells are identified as IgMhigh IgDlow and CD5+, while B-2 cells are IgMlow IgDhigh and
CD5–. Functionally speaking, B-1 B cells are thought to be more “innate-like”, and do not
1

require direct T cell help for activation or class switch; as such, they do not normally show signs
of affinity maturation (Pabst et al., 2013). B-1 B cells also do not populate follicles such as the
Peyer’s patches (PP) or mesenteric lymph nodes (MLN) but rather reside in lamina propria or
peritoneum (Jiang et al., 2004). On the other hand, B-2 B cells represent the more canonical
adaptive immune response and are thought to be mostly T cell dependent for activation. These B2 cells comprise the larger portion of the gut B cell response, and traffic to immune follicles such
as the PP, cecal patch (cP), or isolated lymphoid follicles (ILF), which are collectively referred to
as the gut associated lymphoid tissues (GALT) (Lycke and Bemark, 2017). The remainder of this
review will focus on the development of this population of B cells.
The GALT is lined with various specialized cell types that aid in activation of naïve B
cells (Macpherson et al., 2008). One such group is the follicular associated epithelium (FAE)
which contains various specialized epithelial cells contributing to B cell activation by allowing
the controlled influx of lumen antigens. In particular, microfold cells (M cells) are thought to
have multiple mechanisms for antigen delivery including vesicle mediated bulk transcytosis,
formation of transcellular pores, and various receptor mediated mechanisms of antigen capture
and transcytosis (Mabbott et al., 2013). Indeed, RANKL–/– or RANK–/– mice lacking M cells show
greatly reduced levels of IgA as well as decreased coating of lumen bacteria by sIgA, thus
demonstrating the importance of M cells for gut B cell activation (Rios et al., 2016). The
intestinal epithelium also contains goblet cells which are able to form goblet associated passages
capable of delivering soluble antigens to CD103+ dendritic cells (DCs). These CD103+ DCs are
potent inducers of conventional IgA B cells (McDole et al., 2012). In certain instances such as
stimulation with a virulent antigen, CD103+ DCs have been shown to extend trans-epithelial
processes for direct antigen sampling (Farache et al., 2013; Knoop et al., 2013). Suffice to say,
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there are numerous other mechanisms in which gut antigens can be presented to B cells, and this
section is not meant to be an exhaustive list of all such mechanisms.
Upon antigen encounter and DC stimulation under the FAE, activated B cells upregulate
CCR6 and home towards its ligand CCL20, which is produced in the subepithelial dome (SED)
(Reboldi et al., 2016). Within the SED, TGF-β signaling activates the transcription factor CBFα2
which binds to the Igα germline promoter, resulting in class switch to IgA in an activationinduced cytidine deaminase (AID) dependent manner (Shi and Stavnezer, 1998). The deletion of
TGF-β receptor TβRII in B cells results in IgA deficiency, increase in IgG3 class switch, and the
expansion of B-1 cells (Cazac and Roes, 2000). Recent work has shown that lymphotoxin-α1β2
(LTα1β2) dependent DCs express a large amount of the integrin αvβ8 (Itgb8), which is
responsible to cleaving TGF-β into its active form. The loss of either LTα1β2 or DC specific
deletion of Itgb8 results in a significant loss of IgA B cell activation (Reboldi et al., 2016). While
the role of TGF-β on IgA B cell activation is clear, the actual source of TGF-β is less defined. It
seems likely there are multiple cells producing TGF-β including B cells themselves (Gros et al.,
2014), Tregs, innate lymphoid cells (ILCs), and DCs (Li et al., 2005). While TGF-β is a strong
inducer of IgA B cells, various other regulating molecules such as IL-5, APRIL, iNOS/TNF, and
retinoic acid have shown an ability to modulate IgA activation or production through direct and
indirect mechanisms (Hiroi et al., 1999; Litinskiy et al., 2002; Tezuka et al., 2007; Villablanca et
al., 2011).
Apart from the cytokine signals of the SED, the GALT also contains B cell germinal
centers (GCs) used for B cell affinity maturation and expansion. Of the distributed gut lymphoid
tissues, the PP is the dominant site for IgA B cell activation (Reboldi et al., 2016); unlike
systemic GCs which form following infection or immunization, the PP contains perpetual GCs as
3

a result of the presence of food and microbial antigens (Macpherson et al., 2008). Within the GC
dark zone, antigen activated B cells undergo cellular expansion and somatic hypermutation
(SHM). SHM results in the accumulation of randomized mutations on the heavy and light chains
of the B cell receptor (BCR) and subsequent selection is a process known as affinity maturation,
resulting in the production of antibodies with stronger affinity towards its antigen (Rajewsky,
1996). After a yet to be defined signal, these B cells migrate into the light zone where they
compete for survival signals from follicular helper T cells (T FH) based on the affinity of its BCR
(Victora et al., 2010). The primary survival signal from T FH cells towards activated B cells is the
interaction of CD40L to CD40, and the disruption of this signaling axis results in the termination
of the GC reaction (Bry et al., 2006). However, it should be noted that the lack of CD40L does
not completely abrogate IgA B cell responses. T-independent IgA B cell activation in CD40L –/–
mice has been observed in the peritoneal cavity and PP, albeit with impaired protective function
against common oral challenges such as cholera toxin (Bergqvist et al., 2014).
The GC light zone also contains a network of non-hematopoietic follicular dendritic cells
(FDCs), which contribute to IgA B cell affinity maturation (Suzuki et al., 2010). FDCs present
antigen to B cells in the light zone by trapping free soluble, complement fixed, or immune
complexed antigens on their cell surface. It is through competition for these antigens that B cell
affinity maturation is thought to progress (Heesters et al., 2014). In the case of the PP, IgA
complexes can be seen along the FDC network, suggesting a feedback role for IgA in priming de
novo IgA responses (Zhang et al., 2016).
B cells undergoing the GC reaction can undergo multiple rounds of SHM and selection
before exiting the GC and becoming mature IgA+ memory B cells (MBCs) or IgA plasma cells
(PC); this fate decision is often thought to be a result of BCR signaling strength (Bemark et al.,
4

2016; Biram et al., 2019). These cells will then recirculate through the systemic lymphatics
before draining into the thoracic duct and eventually reseeding the small and large intestines
based on CCR9, CCR10 and α4β7 integrin signals (Hieshima et al., 2014; Kuklin et al., 2001;
Pabst et al., 2004). Here, a subset of CD80/PDL-2 double negative memory IgA B cells are able
to re-enter the GC reaction upon reencounter with its cognate antigen (Zuccarino-Catania et al.,
2014), while the IgA plasma cell population represent a temporally stable population of antibody
secreting cells (Hapfelmeier et al., 2010; Quiding et al., 1991).

B cells and T cells in the MLN
While the focus of the previous section has been the activation of IgA B cells in the
GALT, another site of IgA B cell induction is the MLN. While the MLNs do not have direct
contact with the microbial contents of the lumen, CD103+ DCs do traffic there and have been
shown to activate IgA B cell responses (Pabst, 2012). However, the functional difference
between IgAs generated at the GALT vs. the MLN are unclear, and some studies debate the
requirement of the MLN for IgA mediated immunity (Hahn et al., 2010).
It should be noted however, that the MLNs are a location for T cell activation towards
gut antigens, and in particular the activation of Foxp3+ regulatory T cells (Treg). For example,
Helicobacter species have been shown to be a strong inducer of T regs in the colon draining MLN
(Chai et al., 2017; Nutsch et al., 2016). Other groups have shown a strong IgA induction
capability by CD25+ Tregs using the flagellin specific CBir1 transgenic T cell model (Cong et al.,
2009). Finally, a group of Tregs may seed the formation of follicular regulatory cells (TFR). Their
function may be to limit the number of T FH cells in the GC, as to limit the B:T cell stoichiometry
5

resulting in greater competition for T cell help. Indeed, the deletion of T FR cells has been shown
to adversely impact B cell affinity maturation (Kawamoto et al., 2014).
Similarly, studies with Rorγt+ TH17 polarized CBir1 transgenic T cells also show an effect
on the production of IgA, and depletion of IL-17 receptor (IL-17R –/–) results in a decrease in
intestinal sIgA levels (Cao et al., 2012). Furthermore, studies show a large migration of T H17 into
GCs of the diffuse lamina propria after SFB colonization, (Lécuyer et al., 2014). And there is
some evidence using cell fate mapping techniques demonstrating the conversion of T H17 cells
into TFH cells (Hirota et al., 2013). However, whether these T cell subsets directly aid IgA B cell
activation or first convert to Bcl6+ TFH cells first is currently being studied (Crotty, 2011;
Shulman et al., 2014). Thus, while the MLN may not be the principle site of IgA B cell
induction, it affects IgA B cells through the development of T cell subsets which interact with B
cells.

IgA is transported into the gut lumen by polymeric Ig receptor
While the maturation of naïve B cells into IgA memory and plasma cell populations
results in the generation of IgA antibody, this is not the final step before IgA can interact with
the gut microbiome. That is because IgA secreted by plasma cells in the gut are primarily IgA
dimers (dIgA) linked by the J-chain (Tomasi et al., 1965), which by themselves do not diffuse
into the lumen. However, upon secretion into the lamina propria, the transmembrane
glycoprotein polymeric Ig receptor (pIgR) expressed on the basolateral side of the gut epithelium
covalently binds to the J chain of dIgA (Brandtzaeg and Prydz, 1984) and transports it to the
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apical surface, whereupon it is cleaved (Norderhaug et al., 1999). An 80 kDa portion of pIgR
known as the secretory component (SC) stays attached to dIgA, forming sIgA. pIgR is also
capable of binding to IgM pentamers, also via the J chain. Through this mechanism, IgM is also
able to be secreted into the gut lumen, albeit at a lower rate than sIgA (Brandtzaeg and Prydz,
1984). Hence, the transporter pIgR is crucial for allowing IgA interaction with the gut
microbiome in the lumen.
Because pIgR is cleaved following transcytosis of IgA, there is a 1:1 stoichiometry
between the production of pIgR and sIgA (Kaetzel, 2005). This implies the control of pIgR
expression is tightly correlated with how much sIgA is released into the gut, and the control of
Pigr gene expression based on environmental stimuli will alter the levels of sIgA. Indeed,
examination of the intronic and exon 1 regions of the Pigr gene reveals several cytokine reactive
promoter sites. Briefly, STAT1 and NFκB are two of the primary immune related Pigr promoter
binding proteins that have been discovered (Johansen and Kaetzel, 2011). Both in vitro and in
vivo experiments have shown an upregulation of pIgR production after stimulation with IFNγ,
IL-4, IL-17, TNFα, and various TLR ligands such as LPS (Johansen and Brandtzaeg, 2004).
Thus, it is thought that various infections and inflammatory events can modulate pIgR expression
and the subsequent release of sIgA into the lumen.

The functional role of sIgA in the gut
Upon secretion into the gut lumen, sIgA has been observed to have a myriad of effector
functions on the gut microbiome. Unlike IgG and the systemic humoral response, sIgA is not
thought to mediate a sterilizing immune system such as directing cell killing or complement
7

fixation. Instead, sIgA helps to shape the gut flora through a combination of receptor blockade,
steric hinderance, immune exclusion, modulating host-microbe interactions, and immune
surveillance (Mantis et al., 2011).
The first sIgA effector mechanism reviewed here is the ability to block pathogenic
virulence factors by steric hinderance. One of the most well known examples of this is the sIgA
mediated protection of the host from Vibrio cholerae via the blocking of cholera toxin (CT).
Here, sIgA blockade of CT’s B subunit protein prevented its interaction with the host epithelial
GM1 toxin receptor, and effectively blocks the onset of diarrhea common to cholera infections.
Specifically, the generation of IgA hybridomas from the PP of CT orally vaccinated mice binds
to CT’s B subunit and not the host GM1 receptor, thus showing the mechanism of IgA action is
through blockade of virulence factors (Apter et al., 1993). Another example of sIgA’s ability to
neutralize virulence factors comes from a study of Clostridium difficile, whose toxin A and B
results in enterocolitis in humans and mice. In particular, the authors show that sIgA is more
effective at neutralizing both toxins than an IgG antibody sharing the same variable domain
(Stubbe et al., 2000), thereby reducing the pathology associated with C. difficile colonization.
The ability for sIgA to neutralize pathogenic virulence factors is not limited to bacteria.
sIgA has also been studied in the context of viral infection and toxin ingestion. For example,
during infection with enteric reovirus, several sIgA clones have been isolated which blocks
reovirus type 1 Lang from binding to the host epithelium. Specifically, sIgAs have been
identified which bind to the reovirus adhesin fiber σ1, thereby blocking entry and pathogenesis
(Helander et al., 2004). In an example of blockade against toxins, sIgAs neutralizing ricin have
been described. Following oral immunization of ricin, sIgAs binding to both the ricin enzymatic
and lectin binding domain were isolated. These antibodies were able to protect host cells from
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cytotoxicity when co-administered with ricin toxin (Mantis et al., 2006). From these examples,
we see that sIgA is able to bind a large range of noxious particles for the protection of the host.
Secondly, sIgA can also mediate host defense by a process broadly known as immune
exclusion. By enchaining or agglutinating bacteria, sIgA synergizes with the mucus layer of the
gut and peristalsis to prevent host penetration of potentially infectious bacteria (Deplancke and
Gaskins, 2001). One of the best known examples of this occurs during Salmonella enterica
serovar Typhimurium infection. Here, studies have shown that sIgA targets the LPS O antigen of
the bacterial outer member resulting in distortion of the membrane and loss of motility (Michetti
et al., 1992). sIgA has also been shown to bind to the flagella of S. enterica to further reduce its
motility, thereby preventing its egress deep into the host mucosa (Forbes et al., 2008).
Furthermore, sIgA can enchain S. enterica at the earlier stages of colonization thereby preventing
it’s growth (Moor et al., 2017). In studies of other pathogenic bacteria, sIgA is observed to entrap
Shigella flexneri in the mucus layer, resulting in its excretion through peristalsis. This effector
function of sIgA is due to both its antigen binding domain as well as the SC, likely due to the
SC’s ability to interact with the mucin network (Boullier et al., 2009; McGuckin et al., 2011).
Through its interactions with the mucus layer, IgA has a defined role in preventing bacterial
penetration into the host.
Interestingly, immune exclusion does not seem to be the only way in which sIgA controls
the Shigella pathology. In studies where rabbits were administered Shigella precoated with sIgA
or Shigella alone, the authors found the addition of sIgA dampened the hosts’ inflammatory
response by lowering the expression of TNFα, IL-6, and IFNγ (Boullier et al., 2009). The
dampening of host responses is due to sIgA binding of the outer member O-antigen, which
causes the down regulated the expression of Shigella’s type 3 secretion system; a virulence factor
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typically used for pathogenic entry into the intestinal epithelial cells (Forbes et al., 2011) and a
potent immune stimulator. Thus, by interacting with Shigella, sIgA is observed to modulate
bacterial protein expression, although the exact mechanism for the downregulation of the type 3
secretion system is unknown.
Another example of IgA induced expression change was observed in mice monocolonized with Bacteroides thetaiotaomicron (B. theta). In the study by Peterson and colleagues,
an IgA was isolated that was specific to capsular polysaccharide synthesis 4 (CPS4). The
exposure of B theta to this IgA resulted in the selection of bacteria with lower expression of
CPS4, which had lower survival fitness in the mucosa (Peterson et al., 2007b). By altering B.
theta’s competitive fitness, Peterson and colleagues described a dampening of host inflammatory
pathways including inducible nitric oxygen species and IFNγ. Thus, IgA exerts a selective
pressure on a population of B. theta resulting in less host inflammation.
The ability for IgA to modulate the host immune system is not limited to local cytokine
secretion, nor is it limited to gut IgA. Work by Koch and colleagues examining the role of
maternal IgA and IgGs find mouse pups weened without either had a stronger T cell response
later in life (Koch et al., 2016). Furthermore, the introduction of IgA and IgG in the breast milk
reduced the number of TFH cells in the developing neonate, resulting in fewer T-dependent IgAs
later in life. However, the impact of this observation in adult mice is still not clearly understood.
The concept of quorum sensing by the host and microbe to facilitate homeostasis is interesting,
and it is clear IgA can play a major role. The full complexities of these interactions are an area of
active investigation.
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Finally, sIgA has one more function that at first glance may seem contradictory to
everything we’ve described to this point: its ability to bring antigens into the lamina propria.
Work from Mantis, Corthesy and colleagues have shown sIgA complexed antigens being
selectively acquired by M cells (Mantis et al., 2002). Microscopy studies show fluorescently
labelled biotin conjugated to sIgA, but not IgG or IgM, cluster to the apical surface of M cells.
Furthermore, vesicles within the M cells also showed the presence of fluorescently labelled
sIgA-biotin complex. Another study visualized this IgA mediated uptake process using mice
infected with mouse mammary tumor virus (MMTV) in the presence of an IgA hybridoma
backpack specific to MMTV (Weltzin et al., 1989). The study noted MMTV glycoprotein gp52
conjugated with sIgA was found in systemic circulation in the liver and bile. To further support
the idea of IgA mediated antigen uptake, Rochereau and colleagues demonstrated orally
administered HIV P24 protein conjugated to IgA, but not IgG, enhanced antigen trafficking and
improved systemic B cell responses to P24 (Rochereau et al., 2013).
In order to facilitate reverse transcytosis of antigens, sIgA has been shown to undergo
conformational changes after binding to antigens. This conformational change improved sIgA
binding to receptors expressed on the apical surface of M cells (Duc et al., 2010). Further studies
found Dectin-1 expressed on M cells are responsible for the binding of sIgA complexes
(Rochereau et al., 2013). These studies showed that Dectin-1 binds to the Cα1 domain and
various glycoproteins of sIgA. After Dectin-1 binding and reverse transcytosis, the sIgA-antigen
complex is released into the SED, where CD11c+ CD11b+ DCs expressing the DC-SIGN
receptor appear to be the primary recipient of these new antigens (Baumann et al., 2010). Thus,
the life of the sIgA molecule appears to come full circle, delivering antigens from the lumen into
the SED, with the potential to activate a new round of IgA B cell selection.
11

Summary
The maturation of naïve B cells into memory and plasma IgA B cells is a complex
process. Multiple different physiological locations, cellular subsets, and cellular signals are
involved from the initial antigen encounter, the GC reaction, and the secretion of IgA; each of
which can be modulated based on microbial colonization or inflammatory conditions. It should
not come as a surprise then, that the factors affecting the formation of IgA B cell responses
remains an open question. What bacterial antigens do these B cells see at steady state? What
drives the cross reactive IgA activation versus a more traditional adaptive response? These are
some of the questions actively being pursued at the moment.
While the question of IgA B cell activation is complex, so too is the question of sIgA
function in the lumen. Many of the studies highlighted in the previous section utilized model
antigens in gnotobiotic mice, oral vaccinations, or pathogenic infections. The function of sIgA
during homeostasis against a fully complex microbiome is not clearly defined. The paradoxical
role of sIgA immune exclusion and sIgA immune surveillance is a problem worth addressing.
Are the two functions truly mutually exclusive, or is it dependent on the target bacteria?
Addressing these questions and gaining a better understanding of IgA function has the potential
to unlock many therapeutic innovations, ranging from oral vaccine strategy, to a better
understanding of food allergen responses, to dealing with inflammatory bowel disease.
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Chapter 2: sIgA enhances the priming of gut
B cells

2.1 Abstract

Previous studies show mixed results on sIgA’s impact on priming the gut adaptive
immune response. Depending on the model antigen used, sIgA sometimes blocks T and B cell
activation, and other times help stimulate the immune response. Here, we utilize an in vitro
culturing system to expand gut B cells and test the effects sIgA has on the gut adaptive immune
system under homeostatic conditions with an unaltered microbiome. Interestingly, we see that
the loss of sIgA in Pigr–/– mice results in lowered IgA MBC responses towards commensals. This
loss of reactivity was not seen across all bacteria, but in a specific subset.
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2.2 Introduction
The mammalian gut is colonized by trillions of microbes which are segregated from the
host to maintain homeostasis. A number of mechanisms exist to control host:microbial
interactions, including mucin and antimicrobial peptides at the mucosal surface (Brogden, 2005;
Hancock et al., 2016; Pelaseyed et al., 2014). Another layer of protection is thought to be
provided by adaptive immunity via the secretion of immunoglobulins (Ig) by B cells
(Macpherson et al., 2008; Pabst, 2012). While various Ig isotypes are produced in the mucosa,
IgA is the primary antibody that enters the lumen. Dimeric IgA, but not IgG, produced by B cells
is transported from the lamina propria into the gut lumen by the polymeric Ig receptor (pIgR),
whereupon pIgR is cleaved, leaving the secretory component attached to dimeric IgA forming
secretory IgA (sIgA) (Mantis et al., 2011). Thus, host IgA responses are thought to be important
for maintaining homeostasis to gut bacteria (Koch et al., 2016; Macpherson et al., 2008a; Pabst,
2012).
The role of sIgA has been extensively studied during infection. Examples include the
ability of sIgA to enchain enteropathogens such as Salmonella typhimurium to facilitate bacterial
clearance (Moor et al., 2017), and to neutralize cholera toxin during Vibrio cholerae infection
(Apter et al., 1993). Secretory IgA (sIgA) has also been implicated as a mechanism for the
uptake of bacterial antigens (Brown et al., 2013; Mantis et al., 2002) and facilitate
immunosurveillance of pathogens such as Shigella flexneri (Kadaoui and Corthésy, 2007). Thus,
sIgA is thought to provide an immunologic barrier during infection.
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However, the role of sIgA responses to gut commensal bacteria under homeostatic
conditions is less clear. Previous reports suggest that, similar to its role against pathogens, sIgA
provides immune exclusion by limiting commensal bacterial antigen access to the adaptive
immune system (Cong et al., 2009; Peterson et al., 2007a). For example, presentation of orally
administered flagellin antigen was increased to CBir1 TCR transgenic cells in PigR-deficient
mice (Cong et al., 2009), which lack the ability to transport IgA into the intestinal lumen.
However, two recent studies suggested that IgA could facilitate bacterial growth or colonization.
One study of Bacteroides thetaiotaomicron showed that metabolic utilization of IgA was
required for optimal colonization (Nakajima et al., 2018). A study of Bacteroides fragilis found
that host sIgA was used to gain access to certain gut niches to allow colonization (Donaldson et
al., 2018). These data suggest that the interaction of host immunity and IgA with gut bacteria is
complex and may occur in a bacteria-specific manner. Thus, while it is clear that host immune
responses generate sIgA against gut bacteria during homeostasis (Pabst, 2012; Palm et al., 2014),
it remains unknown whether sIgA facilitates or inhibits the priming of gut B cell responses to
bacteria.
Here, we studied the role of sIgA in shaping the anti-commensal Ig repertoire during
homeostasis. We use the polymeric Ig receptor (Pigr) knockout mouse, which lack the receptor
required for transporting IgA and IgM into the intestinal lumen, but otherwise do not show overt
signs of inflammation (Johansen et al., 1999). To efficiently screen for anti-bacterial IgA and
IgG specificities, we developed an in vitro system to expand small numbers of memory B cells to
collect their secreted Ig. Unexpectedly, we found that sIgA deficient mice show decreased IgA
reactivity towards certain members of the microbiota, suggesting that sIgA facilitated B cell
priming to gut bacteria.
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2.3 Materials and Methods
Ethics Statement
Animal experiments were performed in specific pathogen free facilities in accordance
with the guidelines of the Institutional Animal Care and Use Committee at Washington
University.

Mice
Pigr–/– mice (Johansen et al., 1999) were obtained from H.W. Virgin, and bred Pigr+/–
males to Pigr–/– females. CT2 (Nutsch et al., 2016), CT6 (Lathrop et al., 2011), and OTII (Jax
#004194) TCR transgenic mice have been previously described. Rag1–/– (Jax #002216) and
Foxp3IRESGFP (Jax #006769) were obtained from Jackson Labs.

T cell analysis and adoptive transfer
Naïve TCR transgenic T cells from the mesenteric, axillary, and inguinal lymph nodes,
and spleens, were sorted using a FACAria IIu (Becton Dickenson) based on CD4 + CD25– CD44lo
CD62Lhi expression. Cells were labelled with Cell Trace Violet (Invitrogen) and 2x10 5 T cells
were retro-orbitally injected into 7-8 week old CD45.2 host mice anesthetized with isoflurane.
After 1 week, the CD45.1+ CD45.2– CD4+ transferred T cells were analyzed by flow cytometry
from the MLNs. Activated T cells were gated on CD62Llo CD44hi, Foxp3 expression was
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determined by GFP, and cell proliferation was gated on CTV lo populations. Oral ovalbumin
(50mg) was fed via gastric gavage 24 and 48 hours after adoptive transfer of OTII cells.

B cell analysis and culture
Single cell suspensions of ileal PP, colonic lamina propria, or MLN were analyzed by
flow cytometry. Memory B cell populations were identified as B220 + IgD– CD138– GL7– and
IgA or IgG+. ASCs were identified as B220lo IgD– GL7– and IgA+ or IgG+. MBCs were expanded
in vitro via coculture with NIH-3T3 cells expressing BAFF and CD40L as described (Purtha et
al., 2011). Briefly, MBCs (1-1600/well) were sorted into mitomycin-c treated BAFF and CD40L
expressing 3T3 cells and cultured in 96 well plates and stimulated with IL2, 6, 10, LPS,
Pokeweed mitogen, and CpG DNA. After 7 days, supernatant was harvested and IgA/IgG
quantified by a standard sandwich ELISA using plate-bound anti-mouse IgK capture
(eBioscience), biotinylated anti-mouse IgA or anti-mouse IgG (BD), and HRP Streptavidin
(Biolegend). TMB detection was used and quenched with 1M H 2SO4; detection was performed at
A450. Purified mouse IgA or IgG was used to generate standard curves.

Bacteria FACS and sorting
3 week old Rag1–/– mice were orally gavaged with 200 µL 0.5 g/L vancomycin, 1g /L
neomycin, ampicillin, and metronidazole twice over 48 hours. 72 hours after the first gavage,
Rag1–/– mice were gavaged with total intestinal lumen preparations from Pigr+/– or Pigr–/– mice.
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2 weeks after fecal transfer, intestinal lumen contents and colonic mucus scrapings from Rag1–/–
mice were collected and frozen in 40% glycerol stocks at -80 o C to generate the fecal repository.
For bacteria FACS, fecal stocks from Rag1–/– mice were treated with 5mM L-acetyl cysteine for
10 minutes to disrupt the mucous, washed with PBS, and filtered through 70µm nylon mesh.
20µL were stained with 150µL of Ig containing supernatant in a 96 well U bottom plate on ice
for 1 hour. Ig-stained intestinal samples were then washed twice with PBS and stained with 1mM
DAPI, Dylight anti-mouse IgA, PE anti-mouse IgG, and a FITC isotype control for 1 hour on ice.
After washing, flow cytometry and sorting of bacteria was performed on a BD FACSAria IIu.
Ig+ fractions were sorted directly into a 96 well PCR plate containing 25µL of H 2O.

Bacteria 16S rDNA sequencing
Bacterial 16S rDNA was amplified using Bioline Ranger polymerase and barcoded
primers for the V4 region of the 16S rDNA (Caporaso et al., 2011) and sequenced on the
Illumina MiSEq platform (250 bp paired end reads). OTU picking was performed using
UPARSE (usearch v.9.0.2132)(Edgar, 2013) and taxonomy assigned via uclust method (QIIME
v1.9)(Caporaso et al., 2010) using Greengenes 13.8 database.

Statistical Analysis
Graphpad Prism v8, R v3.5.2, R Studio v1.1.447, and Qiime v1.9 were used for statistical
and graphical analysis. Student’s t test, Mann-Whitney U test, two-way repeated measures
ANOVA, Fisher’s exact test (Prism v8 and R package Stats v3.6.0), and PERMANOVA (R
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package Vegan v2.5-4) were used for between subject analyses. Benjamini-Hochberg FDR
correction (R package Stats v3.6.0) was to correct for multiple comparisons containing normally
distributed P values and Storey Q-value correction (R package qvalue v2.14.1) was used to
adjust for multiple comparisons where P values were left skewed. Outlier detection for high IgA
reactivity utilized the R packages Extremevalues (v2.3.2) and Fitdistrplus (v1.0-14). Heatmaps
were generated using R package Heatmap3 (v1.1.16); OTU and wells distance matrices and
clustering were done using the R package Vegan (v2.5-4). Statistical significance key: * : p <
0.05, ** : p<0.001, *** : p<0.0001, **** : p<0.00001.

19

2.4 Results
sIgA does not affect T cell responses to colonic Helicobacter species
Previous reports suggested that anti-commensal IgA could inhibit T cell responses to gut
bacteria (Cong et al., 2009; Peterson et al., 2007a). Recently, we identified Helicobacter
typhlonius and apodemus as bacterial stimulators (Chai et al., 2017) of peripheral Treg cell
development of TCR transgenic lines CT2 and CT6 (Lathrop et al., 2011; Nutsch et al., 2016).
Helicobacter spp. have also been reported to induce IgA responses in vivo (Arnold et al., 2016).
We therefore asked if activation of these bacterial-reactive T cells was inhibited by sIgA. In
contrast to CBir1 T cells (Cong et al., 2009), the proliferation and Treg development of
transferred naïve CT2 and CT6 cells were not affected by loss of sIgA in Pigr–/– mice (Fig.
2.1.A-C), which were generated in this study by breeding Pigr+/– males with Pigr–/– dams.
Consistent with the data from transferred TCR transgenic cells, we also did not observe
wholesale changes in the frequencies of polyclonal effector or regulatory T cells in the Peyer’s
patches, mesenteric lymph nodes (MLN), or colon lamina propria (cLP) in Pigr–/– compared with
Pigr+/– mice (Fig. 2.2.A-B). To assess whether Pigr–/– mice exhibited alterations in the
presentation of soluble oral antigens in unimmunized mice (Johansen et al., 1999), we examined
OTII responses to oral ovalbumin. Like CT2 and CT6, T cell activation of transferred naïve OTII
cells was unaffected by PigR-deficiency (Fig 2.1.D). Thus, these data suggest that for these
commensal and food antigens, sIgA does not limit T cell activation in the gut.
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sIgA deficient mice show lower IgA reactivity to commensals.
We then asked whether sIgA limits the B cell response to gut commensals. Similar to the
polyclonal T cell populations (Fig. 2.2), no significant differences in the IgA+ memory B cells
(MBC), naïve B cells, or germinal center B cells were seen in the small intestinal Peyer’s Patches
(PP), MLN, and cLP from 7 week old Pigr–/– and Pigr+/– control littermates (Fig. 2.3.A-B). A
small increase was found in the antibody secreting cells (ASC) population within the MLN of
Pigr–/– mice. Overall, the B cell population, like the T cell population, was not markedly affected
by the absence of sIgA in the gut.
Although we did not observe marked changes in the B cell population, the absence of
PigR could still alter the frequency of anti-bacterial B cells. As Pigr–/– mice do not secrete sIgA
into the lumen (Johansen et al., 1999), this precludes the approach of using flow cytometry for
assessing IgA specificity for fecal bacterial (Fig. 2.4.A) (Kau et al., 2015; Palm et al., 2014). An
alternative approach has been to clone from individual IgAs single cells and re-express them to
test specificity (Tiller et al., 2009). However, this is a time intensive approach and cannot be
easily used to analyze the antigen specificities of B cell populations between mice of different
genotypes as only a hundred or so BCR clones can be sampled. Instead of BCR cloning, ex vivo
culture systems have been used to obtain IgA from ASCs that could then be used to label fecal
bacteria. However, individual ASCs do not make sufficient IgA in culture (Cocco et al., 2012) to
assess antigen reactivity at clonal or near-clonal cell numbers.
Because of these issues, we utilized an ex vivo B cell culture system to study the bacterial
specificity of IgA produced by MBCs. We chose to study MBCs from the ileal PP, as the PP are
the primary site for IgA B cell activation in the GALT (Reboldi et al., 2016). Furthermore, the
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ileum contains the highest number of PPs, and IgA B cells from the ileum also appear to be the
most mature compared to those found in the duodenum or jejunum (Biram et al., 2019). IgA +
MBCs were sorted onto NIH-3T3 cells expressing B cell growth factors (Purtha et al., 2011) and
expanded in vitro to secrete IgA antibodies. The antibodies in the supernatant were then used to
stain IgA-free intestinal bacteria and detected by flow cytometry using a fluorescent anti-IgA
antibody (Fig. 2.5.A). Intestinal bacterial preparations of the small and large intestines were
generated by antibiotic treatment followed by oral gavage of Rag1–/– mice with fecal matter
combined from Pigr+/– and Pigr–/– mice. One caveat of this approach is that the microbial
proportions in the Rag1–/– hosts are not identical to that of the donors, although most of the
constituents are present in the repository (Fig. 2.5.B). Another issue is that bacteria present at
low frequency in the repository may be difficult to identify via FACS purification. Finally, flow
cytometry will not detect anti-bacterial IgA that are reactive to soluble antigens or smaller
particles such as outer membrane vesicles (Hickey et al., 2015). However, one advantage of an in
vivo source of bacteria is that they are more likely to express the appropriate array of antigens,
which may not occur with in vitro culture (Hickey et al., 2015). With these considerations in
mind, we reasoned that this ex vivo approach would allow us to directly compare the bacterial
reactive repertoire of PP IgA+ MBCs that develop in the presence or absence of sIgA.
We first assessed the efficiency of culturing IgA+ MBCs from control Pigr+/– mice in
vitro. Approximately 17% of wells seeded at one IgA+ MBC per well produced IgA detectable
by ELISA (Fig. 2.6.A). Of the IgA positive wells, 46% bound bacterial particles as detected by
flow cytometry, giving an estimated ~8% efficiency per sorted cell for generating bacteriareactive IgA. We did not observe a correlation between the IgA concentration in the supernatant
and the percent IgA bound bacteria, suggesting that the IgA binding is antigen specific (Fig
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2.6.B). Furthermore, pIgR-deficiency did not lead to a B cell intrinsic IgA production deficit as
assessed by IgA ELISAs of the in vitro culture supernatants (Fig. 2.6.C). As the limiting factor
in this analysis was the total number of wells that could be analyzed for IgA-bound bacteria by
flow cytometry in a given day, we asked whether increasing the number of MBCs input per well
would allow us to sample a larger proportion of the MBC population in Pigr+/– or Pigr–/– mice.
Comparison of IgA produced by MBCs from Pigr–/– and Pigr+/– mice wells revealed a difference
in the frequency of IgA-bound bacteria at 25 cells/well (Fig. 2.7.A). The difference between
Pigr–/– and Pigr+/– MBCs was diminished or lost at higher cell numbers (100-1000/well),
suggesting that this assay has a saturable component such as the number of IgA-binding sites on
bacteria. Twenty-five cells per well would be predicted based on the Poisson distribution to
result in approximately 1-3 bacteria reactive IgA B cell clones per well, limiting the ability to
accurately count bacterial-specific MBCs present in the population at high clonal frequency as
there maybe multiple instances per well. Nonetheless, we reasoned it would be worth this
tradeoff to capture a substantially greater fraction of the B cell repertoire by using 25
MBCs/well.
To confirm the difference seen between MBCs from Pigr–/– or Pigr+/– mice in the cell
number titration experiment (Fig. 2.7.A), we analyzed supernatants obtained from cultured ileal
PP IgA+ MBCs sorted from 7 mice per genotype (48 well/mouse; 25 cells/well). As before, the
frequency of IgA-bound bacterial particles assessed per well by flow cytometry was decreased
on average from Pigr–/– vs littermate Pigr+/– control MBCs (Fig. 2.8.A). In fact, 24% of IgA
containing wells from Pigr–/– IgA MBCs showed background levels of binding to bacteria
(dashed line, Fig. 2.8.A), in contrast with less than 10% of wells from control Pigr+/– MBCs.
These data suggest that deficiency in sIgA results in decreased generation of bacteria-specific
23

IgA B cells, which is contrary to the hypothesis that sIgA primarily excludes bacteria from
interacting with the adaptive immune system (Cong et al., 2009; Peterson et al., 2007a).

Deficiency in sIgA does not significantly alter the microbiota
One potential explanation for the decrease in IgA B cell reactivity in sIgA deficient mice
would be a large shift in the microbiota between Pigr–/– and Pigr+/– mice, which are weaned as
littermates by sex, but not genotype, into the same cage. sIgA may regulate the abundance of
specific bacteria species (Fadlallah et al., 2018; Macpherson et al., 2008a) and disrupt the
community structure. To address this, we analyzed the microbiota by 16S rDNA sequencing of
lumen contents of the small intestine and colon, as well as bacteria that were associated with the
mucosa. We did not observe significant differences in the microbiota at the operational
taxonomic unit (OTU) or order level taxa between Pigr–/–, Pigr+/–, or Pigr+/+ mice (Fig. 2.9.A,
PERMANOVA). In addition, principle coordinate analysis (PCoA) of Bray-Curtis dissimilarity
distances did not reveal distinct clustering by Pigr genotype (Fig. 2.9.B). Finally, we did not
observe significant differences in alpha-diversity measures between Pigr–/–, Pigr+/–, or Pigr+/+
mice (Fig. 2.9.C). In summary, these data from 7 wk old mice do not reveal a marked shift in the
microbial community resulting from a deficiency in sIgA, suggesting that the increased bacteria
specificity of IgA B cells from PigR-sufficient mice are a result of a differences in microbial
priming of the immune system.
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sIgA increases IgA B cell reactivity towards specific taxa
The unexpected decrease in bacteria-reactive IgA produced by MBCs from sIgA
deficient Pigr–/– mice could be due to a loss of IgA reactivity to specific taxa vs “innate” like IgA
that are cross-reactive to bacteria from many different taxa (Bunker et al., 2017). To address this,
we sorted the IgA-bound bacteria labeled by supernatants from the 25-cell pools and analyzed
their taxonomy by 16S rDNA sequencing (Caporaso et al., 2010). Comparison of the IgA-bound
bacteria from each well revealed a number of OTUs that were consistently found, mostly from
the Bacteroidales order (top rows, Fig. 2.10.A). There were a number of wells that contain
similar levels of IgA by ELISA, but did not show IgA binding by FACS, arguing against the
possibility that these taxa express IgA binding proteins or other features that non-specifically
bind IgA. To assess whether the results seen with 25 cell/well may be due to multiple bacterial
reactive clones per well, we sequenced IgA bound bacteria using IgA generated from wells with
5 MBCs, where we expect only one expanded bacterial reactive clone per well (Fig. 2.10.B).
Together with the 25 well sort data, these data suggest that there are OTUs found in almost all
wells that may represent background in this assay, OTUs that are often found together as a group
in a number of wells suggestive of cross-reactive IgA (Bunker et al., 2017), and OTUs found in
only a few wells suggesting recognition by lower clonal frequency MBCs. Our data are
consistent with the idea that many/most IgA clones exhibit cross-reactivity to multiple species.
We then asked whether there were wells that showed IgA binding to specific taxa above
“background” IgA binding, suggestive of the presence of an IgA clone with high reactivity to
that OTU. We first looked for OTUs that show a high ratio between the IgA bound frequency
divided by its frequency in the total population used for staining. However, this method skewed
towards rare bacteria which had large enrichment ratios due to a small denominator (data not
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shown). Next, we used non-parametric and parametric methods for outlier detection using the
16S frequency in the top quartile or above 2 standard deviations (SD), respectively, for all wells
of both genotypes of a given OTU. While this approach worked for some OTUs, for others it
appeared to result in false positives (e.g. s541 for interquartile range (IQR)) or false negatives
(e.g. s3846 for 2xSD) (Fig. 2.11.A, B). One limitation of these approaches is that they are based
on assumptions regarding the distribution of IgA binding frequency. We therefore examined the
distribution of data across all wells for each OTU by comparing the skewness and kurtosis (Fig.
2.11.C) via a Cullen Frey graph (see Methods), which suggested that the best fit distribution of
frequencies was an exponential distribution. This was further supported by examining the Akaike
information criterion, where the exponential distribution has the best fit (lowest value) compared
with other distributions across all OTUs (Fig. 2.11.D). Use of an algorithm for outlier detection
fitted to an exponential distribution (Fig. 2.11.A, E) allowed us to estimate with greater
reliability the frequency of IgA MBCs wells that show what we will call “high reactivity” to
specific bacteria taxa. Using this method, we found that the presence of sIgA resulted in a
significantly increased frequency of MBCs with high reactivity to a subset of OTUs determined
(Fig. 2.12.A). In fact, OTUs showing a greater than 4-fold difference in the number of IgA high
reactivity wells were preferentially bound by IgA MBCs from Pigr+/– compared with Pigr–/– mice
(Fig. 2.12.B, vertical dashed lines).
Because these experiments used multiple breeders and litters over a period of weeks to
months, we performed a pairwise comparison between the individual sIgA-deficient Pigr–/–
mouse and control Pigr+/– littermate sorted on each experiment day to limit the effects of litter to
litter variation. For each OTU, we subtracted the number of wells with high reactivity IgA from
the Pigr+/– vs its paired Pigr–/– littermate–a positive number indicating a greater number of wells
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with high reactivity to that OTU in the Pigr+/– mouse. For most OTUs, there were more IgA
reactive wells from the sIgA-sufficient mouse (blue, Fig. 2.12.C). However, a subset of OTUs
show increased numbers of IgA reactive wells from the sIgA-deficient mouse (red, Fig. 2.12.C).
Taken together, these data suggest that the presence of sIgA generally enhanced the generation
of high reactivity IgA to specific taxa.
We next asked if the sIgA dependent IgA were targeted based on higher taxonomic
levels, hypothesizing that species of certain taxa may express common antigens. To test this, we
summed the number of wells showing high IgA reactivity at a given taxonomic level as a
proportion of total wells and observed that members of the Bacteroidales order elicit a larger IgA
B cell response in Pigr+/– mice than in Pigr–/– mice (Fig. 2.12.D). Finally, we asked whether
sIgA affected the anti-IgA coverage of the bacterial species that reside within the gut. We were
able to detect wells with high IgA reactivity towards ~60% of the commensal population in Pigr–
/–

mice compared to ~80% in Pigr+/– mice (Fig 2.12.E). In summary, these data suggest that the

presence of sIgA enhanced the frequency of bacterial reactive IgA + MBCs, the proportion of
clones with high reactivity to gut bacteria, and the breath of bacterial recognition by high
reactivity IgAs.
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2.5 Discussion
In this chapter, we show a major role of sIgA is to facilitate B cell responses to
commensal bacteria, contrary to the notion that sIgA inhibits immune interaction with gut
bacteria. These responses appeared to be taxa specific, as Ig responses to OTUs from the
Bacteroidales order show greater dependence on sIgA.
Our data suggest that under homeostatic conditions, sIgA is not required for preventing
wholesale commensal bacterial entry into the lamina propria, consistent with a recent study
(Rogier et al., 2014). Unlike previous studies (Cong et al., 2009; Peterson et al., 2007), we found
that T cell responses to Helicobacter were not increased in the absence of sIgA. These results
may differ because the model systems used previously may not represent homeostatic conditions.
For example, CBir1 T cell activation was assessed to exogenous antigen administered orally and
not antigen endogenously produced by gut bacteria (Cong et al., 2009). Similarly, decreased T
cell responses to B. theta was seen in a monocolonized mouse which also had monoclonal
production of anti-B. theta IgA (Peterson et al., 2007). Another possibility is that Helicobacter,
which does induce IgA responses in our experience as well as others (Xu et al., 2018), can
bypass inhibition by sIgA to gain access to the immune system as it lives in crypts of the colon
and cecum (Pedron et al., 2012). sIgA may still play an immune exclusion role for certain taxa,
as we observed that some OTUs showed increased IgA + MBC responses in Pigr–/– vs. Pigr+/–
mice. In addition, the assay of MBC specificities may not be sensitive to ongoing B cell priming
which could be diminished by pre-existing IgA. Thus, sIgA may inhibit immune activation to
only a subset of luminal antigens.
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Instead, our data suggests that an important role of sIgA during homeostasis is to
facilitate immunosurveillance. We observed that the frequency of anti-bacterial IgA is increased
in the presence of sIgA. Although we do not address how this might occur, a mechanism by
which sIgA facilitates antigen uptake from the gut lumen into the lamina propria was suggested
to involve Dectin-1 (Rochereau et al., 2013). In addition, sIgA may interact with the gut mucin
network (Biesbrock et al., 1991), resulting in adherence of bacterial targets to mucin which may
potentially result in antigen uptake. Future studies will be required to understand the mechanism
by which sIgA facilitates immune priming, and how it fits amongst the various methods by
which commensal bacteria trigger adaptive immune responses in the gut.
OTUs of order Bacteroidales were particularly dependent on sIgA for induction of
adaptive immunity, although the rationale for this is unclear. One interesting question is whether
high reactivity antigen-specific sIgA is necessary for this process. Although further studies are
needed, we speculate that the poly-specificity of many IgA (Bunker et al., 2017), which we
observed in our studies often binding to Bacteroidales members, may facilitate uptake and
subsequent generation of high reactivity bacteria-specific IgA.
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2.6 Figures

Figure 2.1: Pigr–/– mice have normal transgenic T cell activation
(A-D) TCR transgenic responses to gut antigens. TCR transgenic responses to gut antigens.
2x105 naïve CD45.1 OTII, CT2 or CT6 transgenic T cells were transferred into CD45.2 + Pigr+/–
or Pigr–/– hosts. MLN (OTII) or distal MLN (CT2, CT6) were analyzed 7 days post transfer and
donor T cell expression of Foxp3GFP and cellular division (Cell Trace Violet, CTV) was assessed
by flow cytometry. Representative FACS plots are shown in (A) and summarized in (B-D) for
CT2, CT6, and OTII, respectively. Significance determined by Student’s t test. Each dot
represents an individual host and combine 2-3 independent experiments.
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Figure 2.2: Pigr–/– mice have normal polyclonal T cell compartments in the gut
(A) Frequency of helper T cell populations in the GALT. FACS gating strategy and
summarization of IFNγ+, IL17+, or Foxp3+ T cell populations in the cLP, MLN, or PP of 7-8
week old Pigr+/– or Pigr–/– mice were assessed by intracellular staining after PMA + Ionomycin
stimulation. (B) Frequency of follicular T cells in the GALT. PD1 + CXCR5+ CD4+ cells in the PP
or MLN of 7-8 week old Pigr+/– or Pigr–/– mice were assessed by flow cytometry. Statistical
significance determined by Student’s T test (n = 6, 6)
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Figure 2.3: Pigr–/– mice have normal B cell compartments in the gut
(A) Frequency of B cells in the GALT and MLN. FACS gating strategy for B220+ IgA+ IgD–
MBCs or B220lo IgA+ IgD– ASCs is shown on the left. On the right, the frequency of ASCs and
MBCs within the IgD– B cell population of 7-8 week old Pigr+/– or Pigr–/– is shown within the
Ileal PP, colon lamina propria (cLP) or mesenteric lymph node (MLN). Significance determined
by Student’s t test. Each dot represents an individual host and combine 2-3 independent
experiments. (B) FACS gating strategy for ileal PP B cells is shown on the left. On the right, the
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frequency of B220+ IgD– GL7+ IgA+ germinal center cells, or B220+ IgD– GL7+ IgA– memory B
cells of 7-8 week old Pigr+/– or Pigr–/– mice is shown. Statistical significance determined by
Student’s t test (n = 15, 14). (C) Total cell counts within the PP. Statistical significance
determined by Student’s T test (n = 6, 6). Each dot represents data from an individual mouse.
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Figure 2.4: Pigr–/– mice have reduced sIgA in the gut lumen
(A) Fecal IgA assays of Pigr–/– mice. Data shown are (left) FACS gating for IgA bound bacteria
of fecal pellets, (middle) summary of IgA bound bacteria from 7-8 week old Pigr+/– or Pigr–/–
mice, and (right) quantification of free IgA detected in fecal matter by ELISA.
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Figure 2.5: Method to detect anti-bacterial IgA specificity in sIgA deficient mice
(A) Experimental protocol for assessing bacterial reactivity. IgA MBCs are expanded in vitro via
coculture with NIH-3T3 cells expressing BAFF and CD40L. IgA in the supernatant is used to
stain intestinal bacteria from Rag1–/– mice for bacterial flow cytometry and 16S rDNA
sequencing. (B) Bacterial composition of fecal repository vs lumen contents. 16S rDNA
identities of the fecal repository was compared to lumen contents from Pigr+/– or Pigr–/– small
intestine (SI) or colon lumen contents. Numbers indicate how many OTUs are unique or in the
intersection of each source.
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Figure 2.6: Bacteria reactive IgA MBCs represent a fraction of total sorted B cells
(A) Analysis of clonal expansion efficiency. 864 IgA MBCs from Pigr+/– ileal PPs were single
cell sorted and expanded via the coculture system as per (Fig. 2.5.A). The number of wells with
IgA in a given concentration range determined by ELISA is shown in green bars. The standard
curve for IgA ELISA is shown as a blue line. Expanded wells were tested for bacterial reactivity
by flow cytometry and summarized in the table. Data are pooled from 3 independent
experiments. (B) IgA concentration and bacteria binding. IgA concentration from single cell IgA
MBC supernatants after in vitro expansion was quantified by ELISA and compared with the
frequency of bacteria binding. (C) IgA concentration versus IgA MBC source. IgA concentration
from wells containing 25 IgA MBCs from either Pigr+/– or Pigr–/– ileal PPs were determined by
ELISA. Statistical significance determined by Student’s t test.
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Figure 2.7: Optimizing IgA MBC sort numbers for sampling resolution vs depth
IgA bacterial binding and cell numbers used for in vitro culture. IgA MBCs from Pigr+/– or Pigr–
/–

ileal PPs were titrated from 25-1600 cells sorted per well and tested for bacteria-reactive IgA

as per (Fig. 2.5.A). Statistical significance was determined by Student’s t test with Storey fdr
correction (n = 20 wells per group).
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A
25 IgA+ MBCs/well

Figure 2.8: Decreased commensal reactivity of IgA MBCs from Pigr–/– mice
(A) Role for sIgA for bacterial reactive IgA. IgA MBCs from Pigr+/– or Pigr–/– ileal PPs are
sorted (25/well) and assessed for bacterial reactivity as per (Fig. 2.5.A). Percent IgA bound
bacteria from each well is shown. Significance determined by Student’s t test of logged values.
Data are pooled from 7 mice/group, 48 wells/mouse.
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Figure 2.9: sIgA deficiency does not dramatically alter the microbiota
Gut commensal bacteria comparison. (A) Bacterial compositions of Pigr+/–, Pigr–/–, or Pigr+/+
from colon or SI lumen, or colonic mucosal scrapings. Statistical comparison of compositions for
various phylogenetic levels done between genotypes for all 3 gut tissues using PERMANOVA.
(B) PCoA plots of all 3 genotypes and tissue combinations based on weighted Bray-Curtis
dissimiliarty distances. (C) Alpha diversity of bacterial compositions across genotypes and
tissues based on species sampling and Renyi entropy.
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Figure 2.10: 16S of IgA bound bacteria show varying amounts of background binding
(A) OTUs frequencies of IgA-bound bacteria sorted from MBC cultures as per Fig.
2.5.A. Data shown are OTUs in rows and individual wells (25 MBC/well) in columns. Left
41

color key indicates which phylogenetic order the OTU belongs to. Clustering uses BrayCurtis dissimilarity distances. (B) Analysis of 16S frequencies of IgA enriched OTUs
from wells using lower numbers of IgA MBCs. 5 IgA MBCs are sorted per well and used
for sorting bacteria as per (A).
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Figure 2.11: Distinguishing high reactive IgA via outlier detection
(A) Comparison of three different outlier detection methods. 16S frequencies of each bacterial
OTU across all wells is plotted against the predicted cutoffs for outlier detection based on
interquartile range (IQR), 2.5 standard deviations (SD), or outliers based on an exponential
distribution (EXP). Bottom panel displays the frequency of wells where the OTU is not detected
in the IgA enriched fraction. (B) Individual OTU (every 15 th) 16S frequencies from all wells
containing 25 IgA MBCs is shown. IQR, SD, EXP cutoffs are plotted. S numbers are an internal
designation. (C) Distribution of 16S frequencies for select OTUs are shown by Cullen Fray
graphs. Predicted distribution is shown in blue, and bootstrapped values are shown in orange.
OTU taxonomic information as per (B). (D) Akaike information criterion of various modelled
16S frequency distributions. The AIC value for the distribution of 16S frequencies are calculated
for each OTU. Lower values indicate better fit. (E) Outlier detection of “high reactivity” IgA
based on a predicted exponential distribution. Plot shows observed 16S frequencies versus the
residuals based on a predicted exponential distribution. Right upper quadrant highlights the
outliers in red based on a 0.05 two tailed alpha. OTU taxonomic information as per (B).
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Figure 2.12: MBCs from Pigr–/– show decreased IgA reactivity to specific taxa.
(A) Analysis of IgA MBC reactivity at the OTU level. OTUs that elicited significantly different
IGA MBC responses between Pigr+/– or Pigr–/– mice as assayed by the 25 cell/well in vitro assay
per Fig. 2A is shown. Each column represents the log total number of wells with “high
reactivity” for each OTU per mouse. (B) Effect of sIgA on the number of high reactivity antibacterial IgA MBCs. The number of sorted wells with and without high reactivity IgA for a
given OTU were compared between Pigr+/– and Pigr–/– samples in a 2x2 contingency table using
a Fisher’s exact test corrected by Storey fdr (fdr level = 0.1, y-axis). A high reactivity IgA well
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was determined by outlier detection (Fig. S3C-H). The Pigr–/– fraction of all wells with high
reactivity IgA for that OTU between genotypes is shown on the x-axis (dotted lines denote 4 fold
differences). (C) Normalization of high reactivity IgA MBCs across litters. Differences between
the number of high reactivity wells for each OTU were calculated between each Pigr+/– and
Pigr–/– littermate pair. OTUs with more wells in the Pigr+/– samples are blue; more in Pigr–/–
samples are red. (D) The role of sIgA on IgA MBC reactivity towards different taxa. The fraction
of high reactivity IgA wells for a given OTU clustered by phylogenic order per mouse was
compared between Pigr+/– and Pigr–/– genotypes. Statistical significance was determined by
Student’s t test with Storey fdr method. (E) Number of OTUs recognized by high reactivity antibacterial IgA MBCs from Pigr+/– and Pigr–/– mice. The total number of OTUs are from 16S
rDNA sequencing of the lumen of the colon and SI of Rag1–/– mice. An OTU is considered IgA
targeted if found in at least 1 well as an outlier. Statistical significance determined by Fisher’s
exact test.
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Chapter 3: sIgA enhances the IgG responses
towards commensals

3.1 Abstract
While IgA is the dominant antibody response in the mucosa, the IgG response also make
up a significant portion of total intestinal B cells. In the previous chapter, we showed that sIgA
increases the immune priming of IgA MBCs towards commensals. Here, we utilize the
established in vitro B cell culture and screening system to probe the gut IgG response. We find
that similar to the IgA response, gut IgG specifies towards commensals are degraded in the
absence of sIgA. As a result of this loss of IgG specificity, we observe increased morbidity and
mortality when sIgA deficient Pigr–/– mice are challenged with a sepsis modelling gut barrier
breach. Finally, we probe the bacterial specificities of the IgA vs IgG response and find the IgA
response to be more cross reactive towards bacterial antigens than the IgG response.
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3.2 Introduction
The protective role of IgG B cells in systemic immunity is well established (Bruhns,
2012; Vidarsson et al., 2014a). However, despite comprising a large portion of the gut B cell
compartment (Zeng et al., 2016), the role of IgG during homeostasis is unclear. Functionally,
IgG has a different role than its counterpart, IgA. Rather than having the live and let live
functions associated with IgA (chapter 1), IgG mediate the direct killing of microbes, providing
sterilizing immunity. Here, we will briefly review the mechanistic properties of IgG distinct from
IgA.
One of the functions of IgG is the ability to bind complement. IgG on the surface of a
microbe can recruit C1q, which is able to initiate the classical complement pathway. The
activation of complement has two main effects: release of anaphylatoxins (C3a, C5a), and the
assembly of the membrane attack complex (C5-C9). The anaphylatoxins act as immune
stimulators, causing the release of histamine from mast cells, and inducing oxidative bursts from
neutrophils. C3a and C5a also have the ability to stimulate B and T cell expansion and activation
through the C3a and C5a receptors (Sarma and Ward, 2011). The membrane attack complex is
able to form cytotoxic pores on the surface of microbes, and the ability of IgG to induce
hemolysis in bacteria in vitro has been demonstrated (Neuberger and Rajewsky, 1981). It should
be noted that not all isotypes of IgG are equivalent in binding C1q: IgG1 and 3 are the primary
activators in humans (Vidarsson et al., 2014a), while IgG2a, 2b and IgG3 are the primary
activators in mice (Neuberger and Rajewsky, 1981).
A second function of IgG is associated with its activation of various Fcγ receptors
expressed on the surface of various immune cells. Fcγ receptor biology is complicated by the
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number of receptors expressed (7 identified in humans, 5 in mice), and the number of IgG
isotypes expressed (4 in humans, 5 in mice). Like interactions with C1q, not all IgG isotypes will
bind to all Fcγ receptors with equal ability; furthermore, Fcγ receptors represent a family of
receptors with both activating, inhibitory, cell surface expressed and secreted variants (Bruhns,
2012).
Activating Fcγ receptors (FcγRI, IIIA, and IV in the mouse) are expressed by a range of
leukocytes including DCs, monocyte and macrophages, neutrophils, basophils, mast cells,
eosinophils, and natural killer (NK) cells (Bruhns, 2012). These Fcγ receptors associate with the
FcRγ subunit which contain immunoreceptor tyrosine-based activation motifs (ITAM), while IIA
and IIC contains their own ITAM domains. Upon binding to IgG, the clustering of Fcγ receptors
results in the phosphorylation of the ITAM motifs by Src family kinases, resulting in the
recruitment and activation of the tyrosine kinases Syk and ZAP70 (Billadeau and Leibson,
2008). Activated Syk can then interact with various adaptors depending on cell type to induce
calcium signaling and PKC signaling which turns on genes for effector function (Getahun and
Cambier, 2015). Depending on the cell expressing the activating Fcγ receptor, the result can be
degranulation, phagocytosis, cytokine or iNOS production and antibody-dependent cellular
cytotoxicity (ADCC). Therefore, activating Fcγ receptors and complement activation represent
effector functions aimed at the destruction of the IgG targeted microbe.
As previously mentioned, the Fcγ receptor family also contains an inhibitory receptor,
FcγRIIb. FcγRIIb is primarily expressed by B cells, and signals through the use of an
immunoreceptor tyrosine-based inhibitory motif (ITIM). Upon clustering of FcγRIIb, the
phosphatase SHP-1 is recruited and mediates downstream effects (D’Ambrosio et al., 1995).
FcγRIIb is thought to interact with the BCR complex by dephosphorylating CD19 and blocking
49

Pi3K signaling (Getahun and Cambier, 2015); the result of this interaction is the inhibition of B
cell activation or apoptosis. It is thought that FcγRIIb may play a role in affinity maturation,
when follicular DCs are coated with IgG bound antigens. Therefore, only the B cells expressing
the highest affinity BCRs could compete against this negative signal (Fournier et al., 2008).
Finally, a third class of IgG receptor is the neonatal Fc receptor (FcRN). Originally
described as a receptor responsible for transporting IgG into the mammary glands (Brambell,
2004), FcRN has also been shown to prolong IgG serum half-life by aiding in its recycling from
lysosomal degradation (Ghetie et al., 1996). Interestingly, FcRN has also been suggested as a
vehicle for transporting IgG across mucus barriers such as the lung and gut, thereby acting as an
IgG homologue to pIgR (Spiekermann et al., 2002; Yoshida et al., 2004, 2006). However in our
experiments as well as others (Castro-Dopico et al., 2019; Zeng et al., 2016), we do not
traditionally see IgG in the gut lumen of healthy mice. A possible explanation for this
discrepancy could be the use of the human-FcRN genetic knock-in model used by Yoshida et al.
Normally, FcRN is expressed on the gut epithelium in neonatal mice (Bruhns, 2012; Roopenian
and Akilesh, 2007), but downregulated in adults. It is possible that the expression of hu-FcRN in
the mouse model does not accurately reflect physiological levels of FcRN in the gut and
provided a pathway for IgG entry into the lumen that does not normally occur in healthy mice.
Without a bona fide method of transport into the gut lumen in healthy subjects, the study
of IgG and its impact on the commensal population has proven difficult. Instead, IgG has
primarily been studied during infection or inflammation. IgG has been shown to be important for
clearing luminal infections of attaching and effacing bacteria such as Citrobacter rodentium
(Maaser et al., 2004). There is also evidence that IgG may exacerbate inflammation by binding
commensal bacteria in patients with inflammatory bowel disease (Castro-Dopico et al., 2019).
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Whether anti-commensal IgGs are routinely generated at homeostasis, and whether these IgGs
are regulated by the presence of sIgA, remains unclear.
To address this issue, we adapted our in vitro screening system for testing IgA bacterial
specificities in Pigr–/– to test IgG bacterial specificities. This allowed us to bypass the lumen
secretion issue that typical gut IgG studies face, as well as compare the anti-commensal IgG
response in the presence or absence of sIgA. Here, we find that similar to the IgA response, gut
IgG specifies towards commensals are less robust in the absence of sIgA. By cataloguing the gut
IgG response, we were able to compare it with the gut IgA response and find that IgG is less
cross reactive towards gut bacteria than IgA. Finally, we asked if the decrease in IgG responses
due to sIgA deficiency results in weaker protection against gut bacterial infection. We reasoned
that IgG typically mediates clearance of invading pathogens, and a decreased IgG response
would result in susceptibility towards gut bacteria sepsis. Indeed, we find without sIgA, the gut
IgG is less able to clear invading bacteria resulting in increased morbidity and mortality in our
gut sepsis model.
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3.3 Materials and Methods
Ethics Statement
Animal experiments were performed in specific pathogen free facilities in accordance
with the guidelines of the Institutional Animal Care and Use Committee at Washington
University.

Mice
Pigr–/– mice (Johansen et al., 1999) were obtained from H.W. Virgin, and bred Pigr+/–
males to Pigr–/– females. Ighm–/– (µMT) mice were obtained from M. Diamond (Jax #002288).
All mice were on the C57BL/6 genetic background.

B cell analysis and culture
See chapter 2.3 B cell analysis and culture.

Bacteria FACS and sorting
See chapter 2.3 Bacteria FACS and sorting.
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Bacteria 16S rDNA sequencing
See chapter 2.3 Bacteria 16S rDNA sequencing.

Peritoneal bacterial infection
Luminal contents of small intestines and colon from Pigr+/– and Pigr–/– mice were
resuspended in 40% glycerol/PBS and aliquots frozen at -80°C. Frozen stocks were thawed and
grown overnight in 5mL of Brain Heart Infusion (BHI) broth (Sigma-Aldrich 53286) at 37°C
with shaking. The next day, cultures were diluted 1:100 in 5mL fresh BHI broth and expanded
until log-phase growth (OD600 of 0.7 – 0.8), spun down, and resuspended in 500µL PBS. 100µL
was injected I.P. into Pigr+/– or Pigr–/– mice. 24 hours after injection, spleens were collected from
mice and homogenized in 1 mL PBS using a Roche MagNA lyser (6000 RPM, 1 min).
Homogenized spleen was diluted 1:102 and 1:104 in PBS and plated as 10 x 20µL drops on BHI
agar plates, overnight at 37oC. Colonies were then counted for live bacteria before plates were
scraped using a bacteria pick into 500 µL sterile PBS. 5 µL of picked bacteria were used for 16S
rDNA amplification and sequencing.

Pasteurella pneumotropica infection
Pasteurella pneumotropica was isolated from a single colony on BHI agar plates plated
with homogenized spleens from animals infected i.p. with aerobic gut bacterial cultures.
Taxonomy was determined by V1-V5 16S Sanger sequencing using universal 10µM 8F/27F (5’AGAGTTTGATCCTGGCTCAG-3’ and 5’-AGAGTTTGATCMTGGCTCAG-3’) and 1391R
53

(5’-GACGGGCGGTGTGTRCA-3’) primers and matched with P. pneumotropica 16S rDNA V4
MiSeq sequencing. Stocks of this P. pneumotropica isolate were made in 40% glycerol and kept
at -80°C. 7-8 week old mice were injected i.p. with ~2x10 11 CFUs of bacteria in log phase
growth in 100 µl PBS. Mice were monitored every 8 hours for disease progression up to 72
hours. A blinded scorer assessed the severity of infection based on a sepsis disease scale from 06 (0, healthy; 6, dead) (Powers et al., 2015). Spleens were collected from mice requiring
euthanasia (absent righting reflex=score of 4 or 5) or at 72h and homogenized for bacterial CFU
counts.
Blood was obtained from 7-8 week old Pigr+/– or Pigr–/– mice by aortic puncture in
100µL heparin and spun down at 3600xG for 5 minutes to collect plasma Ig. Unpurified plasma
IgG concentrations were quantified by IgK capture ELISA before being used to stain bacterial
isolates (Fig. 5D). Serum IgG was then pooled based on Pigr+/– or Pigr–/– genotype and purified
using Pierce Protein A IgG purification kits (ThermoFisher) per manufacturer instructions. 10µg
of purified IgG was injected retro-orbitally into Pigr–/–mice 2 hours prior to infection with P.
pneumotropica.

Statistical Analysis
See chapter 2.3 Statistical analysis.
Comparisons of linear regressions done by ANCOVA in Prism. Gradient boosted
modeling was done using the gbm package in R (v2.15) with 5 fold cross-validation of a
bernoulli distribution model generated from a random 75% of wells. This model was tested by
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the remaining data. 40-160 iterations were performed for each parameter set. Optimization of
n.minobsinnode, bag.fraction, and interaction.depth for area under the curve (AUC) was
performed prior to final analysis shown in Fig. 5B. Network analyses was done using Gephi
(v0.9.2) using the ForcedAtlas2 model. Comparison of survival curves uses the Mantel-Cox log
ranked test on the Kaplan-Meier curves in Prism. Statistical significance key: * : p < 0.05, ** :
p<0.001, *** : p<0.0001, **** : p<0.00001.
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3.4 Results
sIgA enhances the priming of anti-bacterial IgG
Although IgG is not thought of as the traditional B cell response to gut bacteria during
homeostasis, IgG B cells represent a substantial fraction of the gut B cell population. We
therefore asked whether IgG reactivity to gut bacteria might also be affected by the presence of
sIgA using the same in vitro coculture system. Like IgA MBCs, IgG B cell frequency was not
affected in Pigr–/– mice (Fig. 3.1.A), but IgG supernatants from Pigr–/– PP MBCs (25/well)
bound to a lower frequency of bacteria compared with those from Pigr+/– MBCs (Fig. 3.1.B).
16S rDNA sequencing of IgG bound bacteria revealed that Pigr+/– mice generated more wells
with “high reactivity” anti-bacterial IgG than their Pigr–/– littermates (Fig. 3.2.A, 3.2.B). At the
taxonomic order level, we again see a difference in the number of Bacteroidales specific IgG
MBC wells between Pigr+/– and Pigr–/– mice (Fig. 3.2.C). We also noted that Pigr–/– MBCs had
a lower IgG coverage of the commensal population compared to Pigr+/– littermates (Fig. 3.2.D).
Therefore, similar to priming of anti-bacterial IgA, sIgA increases the priming and activation of
IgG MBCs towards gut commensals.

Commensal specific IgGs exhibit less cross-reactivity than IgA
We also asked if there was a correlation between the frequency of high reactivity IgA vs
IgG wells for any given OTU. When we plotted the average number of high reactivity IgA vs
IgG wells per mouse directed against a particular OTU, we found most OTUs exhibited a strong
correlation between IgA and IgG reactivity, with the majority of OTUs falling within a 90%
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prediction interval of the linear regression (Fig. 3.3.A). However, we noticed a significantly
higher number of high reactivity IgG vs. IgA wells in Pigr+/– mice than in Pigr–/– mice (Fig.
3.3.A, blue vs red line, respectively). This further supports the hypothesis that IgA bound
bacteria experience enhanced sampling by the immune system and thus provides positive
feedback for the induction of IgG responses.
While we observed a number of similarities with IgA, we did note that fewer OTUs were
found in each sorted IgG+ well compared to the IgA+ wells (Fig. 3.3.B, 2.10.A) using very
similar fecal repositories (Fig. 3.3.C). Consistent with the heatmap impression, IgA wells reacted
towards larger segments of the phylogenetic tree than IgG wells (Fig. 3.4.A). To independently
confirm this idea, we utilized network analysis to visualize the relationships of OTUs that are
bound by our IgA or IgG wells. Under this method, we treat each bacterial OTU as a node. Edge
weights are determined by calculating the Pearson’s Correlation, filtering on edges with p < 0.05;
thus, a high correlation between two OTUs indicates they are commonly enriched by a well of
antibodies. Based on graph theory, nodes will “repel” one another unless they are tethered by an
edge; the stronger the edge- the more often two OTUs are enriched by the same wells, the closer
in proximity nodes will maintain. We can see in our IgA samples, the OTUs form a large central
cluster (Fig 3.4.B), meaning these OTUs are often enriched by the same IgAs. This supports the
idea there are cross reactive IgAs. Conversely, we see much less OTU clustering from the IgG
samples, suggesting IgG is less cross reactive. This is further supported by the average degree
measurement of the networks, measuring the average number of edges from each node. IgA
OTUs have a much higher degree (51.26) compared to IgG (17.36) (Fig 3.4.C). Together, these
data support the idea there are more cross reactive IgAs than IgGs against commensal bacteria.
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Increased susceptibility to bacterial infection in Pigr –/– mice due to decreased pre-formed IgG
In contrast to IgA, IgG has a well described pathogen neutralization and clearance
function. This led us to hypothesize that pre-existing anti-bacterial IgG may act as a safeguard
against bacterial entry and sepsis in case of barrier breach. To model this, we asked whether gut
bacteria would be more efficiently cleared after i.p. injection into Pigr+/– vs –/– hosts. At 24 hours
post injection of aerobic luminal bacteria expanded in vitro, we sacrificed the mice and assessed
the bacterial burden in the spleen. Consistent with our hypothesis, there were significantly higher
bacterial CFUs in Pigr–/– mice compared to Pigr+/– littermates (Fig. 3.5.A), suggesting that sIgA
sufficient mice are better able to control peritoneal infection by aerobic commensal bacteria.
16S rDNA sequencing of the bacterial colonies from the splenic lysate revealed that these
bacteria were mostly from the Enterococcus and Streptococcus genus (Fig. 3.5.B). One
particular OTU, Pasteurella pneumotropica, was preferentially found in Pigr–/– but not Pigr+/–
splenic cultures (Fig. 3.5.C). P. pneumotropica was rarely identified as a bacterial OTUs
recognized by IgA or IgG MBCs in our in vitro assay, likely as it was not found or found at very
low frequency in our repository and therefore difficult to detect (Fig. 3.5.D). To further study the
immune response to P. pneumotropica, we isolated a pure culture from our colony with the
identical V4 16S rDNA sequence (Fig. 3.5.E). I.p. injection of only P. pneumotropica resulted in
increased morbidity and mortality in Pigr–/– mice (Fig. 3.6.A). Splenic CFU counts were high
from mice that were euthanized due to morbidity (Fig. 3.6.B), and absent or low in mice alive at
the conclusion of the study (72h), consistent with the hypothesis that disease is caused by
dissemination of P. pneumotropica. Thus, these data show that Pigr–/– mice are more susceptible
to peritoneal infection by commensal aerobes such as P. pneumotropica.
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To determine whether B cells were important for protection against P. pneumotropica,
we i.p. infected B cell deficient µMT (Ighm–/–) mice. Compared to control Pigr+/– mice, µMT
mice were highly susceptible to infection, often expiring within 6 hours after injection (Fig.
3.7.A). This suggested that B cells were essential for protection in this model. To establish that
this protective effect was due to IgG, we purified plasma IgG from either Pigr+/– or Pigr–/– mice.
We found that Pigr+/– mice had substantially higher titers of anti-P. pneumotropica IgG than
Pigr–/– mice as assessed using flow cytometry to cultured P. pneumotropica (Fig. 3.7.B). This
appeared to be bacteria specific, as increased binding of Pigr+/– IgG was not seen to E.
casseliflavus, which showed no significant outgrowth in our early screens, or C. rodentium, a
pathogen not found in our mouse colony (Fig. 3.7.B). Finally, we asked if administration of
purified IgG could protect Pigr–/– mice from P. pneumotropic peritoneal infection. Consistent
with the in vitro IgG binding data, IgG harvested from Pigr+/– mice injected i.v. was more
protective against P. pneumotropica infection that that from Pigr–/– mice (Fig. 3.7.C). Taken
together, we conclude that the presence of sIgA results in the generation of higher serum titers of
anti-P. pneumotropic IgG protective against peritoneal infection by this commensal aerobe.
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3.5 Discussion
In this chapter, we show that sIgA enhances the gut IgG MBC response. Like the effect
of sIgA on the gut IgA MBC compartment, the increase in IgG reactivity towards gut bacteria is
OTU specific, and particularly increases reactivity towards bacteria belonging to the
Bacteroidales order. Furthermore, comparing the gut IgA response to the IgG response against
bacteria revealed IgA is significantly more cross reactive towards bacteria; being able to bind to
OTUs spanning across multiple phylogenetic genuses and families. Lastly, we demonstrate the
deficiency of IgG bacterial reactivity in Pigr–/– mice results in susceptibility to sepsis when
challenged with gut bacteria.
An unexpected result in this study was the observation that IgG responses to gut bacteria
are commonly elicited during homeostasis, and that this was in part dependent on sIgA. These
data may explain why there is a large population of IgG B cells in the gut generated during
homeostasis. We hypothesize that these IgG B cells provide a pre-formed IgG response in case
of barrier breach. While anti-bacterial IgG may contribute to pathology with extensive mucosal
injury such as that seen in ulcerative colitis (Castro-Dopico et al., 2019), our data, as well as
generally accepted dogma, suggests that IgG is typically protective (Vidarsson et al., 2014b).
Consistent with this, we observed that aerobic bacteria such as P. pneumotropica
introduced intraperitoneal were more lethal in mice without sIgA. However, P. pneumotropica
may not be the only gut bacteria that is cleared by sIgA dependent IgG; a caveat to our study is
the way we cultured the total lumen bacteria before injection (Fig 3.5.A). By culturing on BHI
agar plates, aerobic conditions, and 37o, we are selecting for a very particular subset of bacteria,
therefore biasing our initial screen. This is probably why we did not see any outgrowth of
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Clostridiales members in the spleen, despite their high representation in the gut (Edwards et al.,
2013; O'Brien et al., 2071). A change of media, and anaerobic conditions may reveal a further
subset of bacteria which Pigr–/– are susceptible towards.
One interesting difference between IgG and IgA was their spectrum of binding to
bacteria. Both the raw data and computational modelling suggest fewer cross reactive IgGs than
IgA. This is consistent with the notion that IgG and IgA memory cells do not arise from an
identical pool of naïve B cells. IgA MBCs are formed from both follicular and extra follicular
sources, whereas IgG MBCs come from predominantly follicular sources (LeBien and Tedder,
2008). While extra follicular and T independent mechanisms of IgA class switch have been
described in isolated lymphoid follicles of the lamina propria (Macpherson et al., 2000), the data
for extra follicular generation of IgG B cells is not clearly defined in the gut. Future studies are
required to show that polyreactive IgA MBCs arise from a different developmental origin than
high reactivity bacterial-specific IgG and IgA MBCs.
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3.6 Figures

Figure 3.1: Decreased commensal reactivity of IgG MBCs from Pigr–/– mice
(A) Frequency of IgG MBCs in the ileal PP. FACS gating of IgD – B220+ IgA– IgG+ MBC
populations on the left and quantified on the right between Pigr+/– or Pigr–/– mice. Statistical
significance determined by Student’s t test (n = 15, 17). (B) Role for sIgA in generating bacteria
reactive IgG. IgG MBCs from Pigr+/– or Pigr–/– ileal PPs were sorted (25/well) and assessed for
bacterial reactivity as per Fig. 2.5.A. Percent IgG bound bacteria from each well is shown.
Significance determined by Student’s t test of logged values (n = 6 mice/group, 24 wells/mouse).
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Figure 3.2: IgG MBCs from Pigr–/– show decreased reactivity to specific taxa
(A) Effect of sIgA on the number of high reactivity IgG wells. Analysis was performed as per
Fig. 2.12.B for outlier detection of 16S rDNA sequencing data from sorted IgG + bacteria using
supernatant from Pigr+/– and Pigr–/– IgG MBCs. (B) Analysis of IgG MBC reactivity at the OTU
level. OTUs with significantly different numbers of “high reactivity” IgG wells are shown here
as per Fig. 2.12.A. (C) The fraction of high reactivity IgG MBC responses towards OTUs of a
given order was compared between Pigr+/– and Pigr–/– samples as per Fig. 2.12.D. (D) Number
of OTUs recognized by high reactivity IgG MBCs from Pigr+/– and Pigr–/– mice as per Fig
2.12.E.
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Figure 3.3: Comparison of anti-bacterial reactivity of IgA and IgG MBCs
(A) Correlation of IgA MBC and IgG MBC bacterial reactivity. Data shown are the average
number of IgA vs IgG wells across all samples that show high reactivity for an OTU by
genotype. Linear regression between IgA and IgG shown in solid lines; difference in slopes is
significant by ANCOVA. Shaded areas indicate the 90% confidence interval for the best fit line.
(B) OTUs frequencies of IgG-bound bacteria sorted from MBC cultures as per Fig. 2.5.A. Rows
show individual bacterial OTUs, and columns show individual wells (25 IgG MBC/well).
Clustering and color key as per Fig. 2.10.A. (C) Fecal repository composition over multiple
experiments. 5-6 samples of total bacteria for each experiment set as per Fig. 2.8.A and 3.1.B
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were FACS sorted. 16S rDNA frequencies are shown for the total bacteria content. Clustering
and color key as per Fig. 2.10.A use Bray-Curtis distances.
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Figure 3.4: Computational modelling of IgA vs IgG reactivity to bacteria
(A) Taxonomic breadth of IgA and IgG wells towards commensal bacteria. The number of
phylogenetic genus, families or orders enriched by each well is shown. Median indicated by
horizontal line. Significance between IgA and IgG determined by Mann-Whitney U test. (B)
Network analyses of IgA- or IgG-bound bacteria. Each node is a bacterial OTU. Edge distances
are calculated via Pearson’s correlation for the association of 16S frequencies between the two
OTUs across all IgA or IgG samples. Network modelled using Gephi with ForcedAtlas2
parameters. Color key indicates phylogenetic order of the OTU. (C) Network analysis
distribution of degrees. Plots show the average number of degrees, or edges, each OTU nodes
possess for IgA and IgA wells. Larger degree values indicate a higher likelihood of OTUs being
enriched by the same well.
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Pasteurella pneumotropica (isolate) 16S Sequence
TACCNGCAGTCGAACGGTAGCACGAGAAAGCTTGCTTTCTTGCTGACGAGTGGCG
GACGGGTGAGTAATGCTTGGGAATCTGGCTTATGGAGGGGGATAACTACTGGAAA
CGGTAGCTAATACCGCATAAGGTCTAAGGACAAAAGGGGGCGTAAGCTCTTGCCAT
AAGATGAGCCCAAGTGGGATTAGGTAGTTGGTGAGGTAATGGCTCACCAAGCCTG
CGATCTCTAGCTGGTCTGAGAGGATGGCCAGCCACACCGGGACTGAGACACGGC
CCGGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCGCAATGGGGGGAACCCT
GACGCAGCCATGCCGCGTGAATGAAGAAGGCCTTCGGGTTGTAAAGTTCTTTCGG
TGATGAGGAAGGTGATAAGGTTAATACCCTTATTAATTGACGTTAGTCACANAANAA
GCACCGGCTAACTCCGTGCCAGCANCCGCGGTAATACGGAGGGTGCGAGCGTTAA
TCGGAATAACTGGGCGTAAAGGGCACGCAGGCGGATTTTTAAGTGAGGTGTGAAA
GCCCCGGGCTTAACCTGGGAATAGCATTTCANACTG
Pasteurella pneumotropica (spleen recovery) 16S sequence
TACGGAGGGTGCGAGCGTTAATCGGAATAACTGGGCGTAAAGGGCACGCAGGCG
GATTTTTAAGTGAGGTGTGAAAGCCCCGGGCTTAACCTGGGAATAGCATTTCAGAC
TGGGAATCTAGAGTACTTTAGGGAGGGGTAGAATTCCACGTGTAGCGGTGAAATGC
GTAGAGATGTGGAGGAATACCGAAGGCGAAGGCAGCCCCTTGGGAATGTACTGAC
GCTCATGTGCGAAAGCGTGGGGAGCAAACAGG

Figure 3.5: Pigr–/– mice are more susceptible to IP challenge from aerobic bacteria
(A) Intraperitoneal infection of aerobic gut bacteria. 2x109 CFUs of aerobically cultured
commensal bacteria from the gut lumen were injected i.p. into Pigr+/– or Pigr–/– mice. Splenic
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colony counts were obtained 24 hours later on BHI agar plates. Statistical significance
determined by Student’s t test (n = 13 and 11). (B) The effect of sIgA on splenic bacteria after
peritoneal infection.16S frequency of live bacteria cultured on BHI agar from the spleens of 7-8
week old Pigr+/– or Pigr–/– 24 hours post i.p. injection with aerobically grown gut bacteria. (C)
Frequency of P. pneumotropica 16S sequences from splenic cultures. BHI agar plates from (A)
were scraped and sequenced for 16S rDNA. 16S frequencies of P. pneumotropica are shown (n =
13 and 11 from 3 independent experiments). Significance determined by Mann-Whitney U test.
(D) Frequency of P. pneumotropica from the ex vivo MBC screens. 16S rDNA frequencies of P.
pneumotropica in the IgA enriched fractions from Fig. 2.12.B, IgG enriched fractions from Fig.
3.2.A, or the fecal library described in Fig. 2.5.B. (E) 16S rDNA sequence of P. pneumotropica
16S rDNA sequence based on V1-V5 sequencing of cultured isolates (top) and 16S rDNA
sequence based on V4 sequencing of live bacteria collected from the spleen as per (A) (bottom).
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B

P. pneumotropica i.p.

Figure 3.6: Pigr–/– mice are more susceptible to IP challenge from P pneumotropica
(A) Effect of sIgA on P. pneumotropica infection. 2x1011 CFUs of P. pneumotropica were
injected i.p. into Pigr+/– or Pigr–/– mice. Survival (left) and morbidity/mortality score (right) was
monitored for 72 hours. Scoring: 1=Animal is bright and alert; 2=Alert but less active, with
spontaneous movement; 3=Huddled with ruffled fur, decreased or no spontaneous movement;
4=Hunched and ruffled, animal does not move when touched, and “righting reflex” absent;
5=Recumbent; 6=Death. Statistical significance determined by log rank test (left) and repeated
measures ANOVA (right) (n= 21 and 18 from 3 independent experiments).
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Figure 3.7: IgG is protective against IP challenge from P pneumotropica
(A) Requirement for B cells on P. pneumotropica infection. P. pneumotropica was injected IP
into 7-8 week old µMT or Pigr+/– mice. Disease progress was tracked over 72 hours; historic
Pigr+/– and Pigr–/– data plotted in dotted lines for reference. Left panel shows survival curve.
Right panel tracks disease score as per Fig. 3.6.A. (B) Serum IgG reactivity to bacterial isolates.
Serum from Pigr+/– or Pigr–/– mice was tested for IgG reactivity towards P. pneumotropica, E.
casseliflavus, or C. rodentium, by flow cytometry; negative control is no serum added. Statistical
significance determined by ANOVA (n = 4 per group). (C) Effect of IgG on P. pneumotropica
infection. IgG was purified from the serum of Pigr+/– or Pigr–/– mice and injected i.v. into Pigr–/–
mice 2 hours prior to i.p. infection with P. pneumotropica and assessed as per Fig. 3.6.A (n = 16
Pigr+/– + PBS, 9 Pigr–/– + Pigr+/– IgG, and 10 Pigr–/– + Pigr–/– IgG over 2 independent
experiments).
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Chapter 4: Concluding Remarks and
Future Directions
sIgA increases gut B cell reactivity towards bacteria
Our data showed that in sIgA deficient Pigr–/– mice, the activation of IgA and IgG MBCs
towards gut bacteria is impaired (Figures 2.8, 3.1). We hypothesize this loss of reactivity is due
to a reduction in the influx of bacterial antigens into the SED and GC caused by the lack of sIgA
mediated immune sampling. This defect in IgA and IgG MBC priming effected the immune
response against certain bacterial OTUs more than others, suggesting certain species are more
susceptible to sIgA mediated antigen uptake. There may be multiple reasons for this: certain gut
species may naturally bind more sIgA than others, or they colonize a gut niche that is in closer
proximity to the receptors responsible for sIgA retro-transport (Pedron et al., 2012). It would be
interesting to see further experiments aimed at understanding the reason behind sIgA dependent
immune activation.
On the other hand, some OTUs generated higher IgA and IgG MBC responses in Pigr–/–
mice. There were slightly higher IgA and IgG reactivities detected towards members of the
Erysipelotrichales and Coriobacteriales orders, respectively (Fig. 2.12.D, 3.2.C). While not
statistically significant, this does suggest that sIgA can sometimes play a dominantly immune
exclusionary function towards certain OTUs (Deplancke and Gaskins, 2001; Forbes et al.,
2008b; Moor et al., 2017). One benefit of our in vitro modelling system was its ability to not
only detect the direction of the gut B cell response, but also approximate the magnitude of the
response. Thus, we were able to roughly differentiate between OTUs that benefit or are inhibited
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by sIgA regarding B cell activation.

Clinical implications of sIgA immunosurveillance
A challenge for understanding the role of IgA is that human patients with IgA deficiency
are often undiagnosed and do not exhibit a high degree of immunodeficiency (CunninghamRundles, 2001). While this may be in part due to the improved hygiene of modern man, IgAdeficient patients do show increased frequency of recurrent sinopulmonary infections
(Cunningham-Rundles, 2001), and increased mortality following liver transplantation (Van Thiel
et al., 1992). Although future studies will be required to determine if the sIgA dependent
response we observe in the gut are also seen in the upper airway, our results lead us to speculate
that these issues may, in part, be due to loss of IgG responses in the absence of IgA.
Our work demonstrating the connection between the gut IgA and IgG response adds to
the growing body of literature on how the gut microbiome can affect the systemic immune
response. It may be possible to leverage this concept into developing an oral vaccine strategy by
inoculating a subject with viral peptides conjugated to IgA. This should in theory generate an
IgA as well as IgG response with systemic protection. Indeed, a proof of principle study of this
was recently published for sIgA-HIV p24 immunization in mice (Rochereau et al., 2015). In
addition, these findings may also have implications in regards to maternal IgA found in breast
milk, which we predict will facilitate infant immunity to gut bacteria. Although the effect of
maternal IgA and IgG has been interpreted as decreasing immune effector T cell activation
presumably via immune exclusion (Koch et al., 2016), we speculate that an alternative possibility
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may be that maternal sIgA facilitated education of the anti-commensal response which led to the
generation of tolerogenic, rather than pro-inflammatory, T and B cell responses.
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